Sex‐specific autistic endophenotypes induced by prenatal exposure to valproic acid involve anandamide signalling. (9th August 2018)
- Record Type:
- Journal Article
- Title:
- Sex‐specific autistic endophenotypes induced by prenatal exposure to valproic acid involve anandamide signalling. (9th August 2018)
- Main Title:
- Sex‐specific autistic endophenotypes induced by prenatal exposure to valproic acid involve anandamide signalling
- Authors:
- Melancia, Francesca
Schiavi, Sara
Servadio, Michela
Cartocci, Veronica
Campolongo, Patrizia
Palmery, Maura
Pallottini, Valentina
Trezza, Viviana - Abstract:
- Abstract : Background and Purpose: Autism spectrum disorder (ASD) is more commonly diagnosed in males than in females. Prenatal exposure to the antiepileptic drug valproic acid (VPA) is an environmental risk factor of ASD. Male rats prenatally exposed to VPA show socio‐emotional autistic‐like dysfunctions that have been related to changes in the activity of the endocannabinoid anandamide. Here, we have investigated if prenatal VPA induced sex‐specific autistic endophenotypes involving anandamide signalling. Experimental Approach: We studied sex‐specific differences in the ASD‐like socio‐emotional, cognitive and repetitive symptoms displayed during development of Wistar rats of both sexes, prenatally exposed to VPA. The involvement of anandamide was followed by Western blotting of cannabinoid CB1 receptors and by inhibiting its metabolism. Key Results: Female rats were less vulnerable to the deleterious effects of prenatal VPA exposure on social communication, emotional reactivity and cognitive performance than male rats. Conversely, as observed in male rats, prenatal VPA exposure induced selective deficits in social play behaviour and stereotypies in the female rat offspring. At the neurochemical level, prenatal VPA exposure altered phosphorylation of CB1 receptors in a sex‐specific, age‐specific and tissue‐specific manner. Enhancing anandamide signalling through inhibition of its degradation reversed the behavioural deficits displayed by VPA‐exposed animals of both sexes.Abstract : Background and Purpose: Autism spectrum disorder (ASD) is more commonly diagnosed in males than in females. Prenatal exposure to the antiepileptic drug valproic acid (VPA) is an environmental risk factor of ASD. Male rats prenatally exposed to VPA show socio‐emotional autistic‐like dysfunctions that have been related to changes in the activity of the endocannabinoid anandamide. Here, we have investigated if prenatal VPA induced sex‐specific autistic endophenotypes involving anandamide signalling. Experimental Approach: We studied sex‐specific differences in the ASD‐like socio‐emotional, cognitive and repetitive symptoms displayed during development of Wistar rats of both sexes, prenatally exposed to VPA. The involvement of anandamide was followed by Western blotting of cannabinoid CB1 receptors and by inhibiting its metabolism. Key Results: Female rats were less vulnerable to the deleterious effects of prenatal VPA exposure on social communication, emotional reactivity and cognitive performance than male rats. Conversely, as observed in male rats, prenatal VPA exposure induced selective deficits in social play behaviour and stereotypies in the female rat offspring. At the neurochemical level, prenatal VPA exposure altered phosphorylation of CB1 receptors in a sex‐specific, age‐specific and tissue‐specific manner. Enhancing anandamide signalling through inhibition of its degradation reversed the behavioural deficits displayed by VPA‐exposed animals of both sexes. Conclusions and Implications: These findings highlight sexually dimorphic consequences of prenatal VPA exposure that may be related to sex‐specific effects of VPA on endocannabinoid neurotransmission in the course of development and introduce a new therapeutic target for reversing autistic‐like symptoms in both sexes. … (more)
- Is Part Of:
- British journal of pharmacology. Volume 175:Number 18(2018)
- Journal:
- British journal of pharmacology
- Issue:
- Volume 175:Number 18(2018)
- Issue Display:
- Volume 175, Issue 18 (2018)
- Year:
- 2018
- Volume:
- 175
- Issue:
- 18
- Issue Sort Value:
- 2018-0175-0018-0000
- Page Start:
- 3699
- Page End:
- 3712
- Publication Date:
- 2018-08-09
- Subjects:
- Pharmacology -- Periodicals
Chemotherapy -- Periodicals
Drug Therapy -- Periodicals
Pharmacology -- Periodicals
615.1 - Journal URLs:
- http://bibpurl.oclc.org/web/21844 ↗
http://onlinelibrary.wiley.com/journal/10.1111/(ISSN)1476-5381/issues ↗
http://www.pubmedcentral.nih.gov/tocrender.fcgi?journal=282&action=archive ↗
http://onlinelibrary.wiley.com/ ↗
http://www.nature.com/bjp/index.html ↗ - DOI:
- 10.1111/bph.14435 ↗
- Languages:
- English
- ISSNs:
- 0007-1188
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 2314.700000
British Library DSC - BLDSS-3PM
British Library STI - ELD Digital store - Ingest File:
- 10957.xml